Clinical Trials Browser

Multiple Myeloma

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma

Biliary Tract Neoplasms, Digestive System Diseases

Melanoma, Skin Neoplasms

Neoplasm Metastasis, Neoplasms

Uveal Melanoma

Prostatic Neoplasms

Primary Central Nervous System Lymphoma (PCNSL)

Mesothelioma, Malignant

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Nasopharyngeal Carcinoma

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Carcinoma, Hepatocellular, Liver Neoplasms

Prostatic Neoplasms, Castration-Resistant

Prostatic Neoplasms

Salivary Gland Neoplasms

Meningeal Carcinomatosis

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Microsatellite Unstable Colorectal Cancer

Glioma, Recurrence

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Fallopian Tube Neoplasms, Ovarian Neoplasms

Neoplasms, Pancreatic Neoplasms

Brain Neoplasms

Urinary Bladder Neoplasms, Melanoma

Advanced Biliary Tract Cancer

Small Cell Lung Carcinoma

Colonic Neoplasms

Brain Neoplasms, Ependymoma, Medulloblastoma, Meningioma, Pinealoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Thyroid Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Spinocerebellar Degenerations, Colorectal Neoplasms

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Carcinoma, Renal Cell

Biliary Tract Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis, Pancreatic Neoplasms, Cholangiocarcinoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Uveal Melanoma

Clinical Trials

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

METIMMOX

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

CheckMate 9KD

Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

CheckMate 6DW

Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

INSPIRE

Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

CheckMate 650

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

Ipilimumab and Nivolumab in Leptomeningeal Metastases

Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer

TG4010 and Nivolumab in Patients With Lung Cancer

CheckMate142

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

TOP1705

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

PICASSO

Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

NGS as the First-line Treatment in Advanced Biliary Tract Cancer

Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

NIVOTAX

Nivolumab Plus Ipilimumab in Thyroid Cancer

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia

Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma

CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease

DEPEND

IMPACT

OPTIMA-II

Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver